Case Analysis : Bristol Myers Squibb

The case consists of two major pharmaceutical companies that joint to collaborate their research and pharmaceutical technologies to start a joint venture in India. Both have valuable resources that have benefited both companies during the joint venture. Now both are questioning if there is still any value in maintaining the joint venture in India and will be deciding what will be the best route to take. Ranbaxy Laboratories wants to be bought out, but Eli Lilly is worried of the financial implications of such move.

The case Pierce v. Ortho Pharmaceutical Corp. was over if employee at will has a cause of action against her employers. Dr. Pierce refused to continue a project that she viewed it as medically unethical, however the employer continued with project and suggest for her to work on other project. In this case there are 3 key stakeholders Dr. Pierce, Ortho Pharmaceutical Corp. and Public (Halbert & Inguli, 2014).

As consultant to Sanders and Myers, I would suggest they rethink the continuation of economic value added (“EVA”) bonus payout process. The proposed EVA bonus payout structure is supposed to be an objective way to gauge and reward employee performance; however, through no fault of their own, the Dermatology group is slated to undergo severe ebbs and flows in their incentive and could potentially wreak havoc on employee morale and retention.

On July15, 2016 Douglas Runnion completed his high school education at the Abraxas center. Since his last court appearance Douglas has made little to no progress in treatment. Douglas continues to remain steady in his consistent negative behaviors. Therefore, the Abraxas treatment team is asking that Douglas be discharged from the program. Abraxas recommends that Douglas continues to be afforded extensive sex offender specific treatment, family therapy, and anger management.

For many types of cancers, we have been using the same base drug (first line treatment) for ten years or even longer. As companies find new drugs to fight the cancers, they hope that it will be the miracle drug that will eradicate the cancer, but it usually isn’t. When they reach this conclusion, instead of returning to the chalkboard and continuing to work to improve the drug, they put the drug on the market as is, and hope it will achieve something. Not only are they putting these drugs on the market but they put price tags on them that would bankrupt anyone without some sort of third party payer. The combination of all of these drugs make up what doctors

Value: Angiomax is a blood-thinning drug, or anticoagulant, used in emergency coronary heart care. Angiomax is positioned as an alternative to heparin, the most commonly used anticoagulant in emergency coronary heart care, so to assess Angiomax value to a hospital is required to compare these two drugs.

Jennifer Erickson was employed by Bartell Drug Company. Jennifer sued the company because its insurance plan failed to provide coverage for prescription contraceptives. She alleged that this was a form of sex discrimination under Title VII and a violation of the Pregnancy Act (PDA). Her employer defended by arguing that its failure to provide coverage for prescription contraceptives did not violate Title VII or the PDA because prescription contraceptives were voluntary, were preventive, were used by women only, and did not treat or prevent an illness or disease and because control of one’s fertility choices was not pregnancy, childbirth, or a related medical condition under PDA. Bartell Drug Company did cover vasectomy surgery for men. Is preventing pregnancy for women only a form of sex discrimination? Is it a form of pregnancy

statin), and Zostavax (a vaccine for prevention of shingles in adults older than 60 years of

The Directors and officers shall perform the duties enjoined on them by law and the by-laws of the corporation. They act as agents or representatives of the Corporation in carrying out its rights and obligations provided by law. Directors who directed the affairs of the Corporation in bad faith, gross negligence, and those involving a conflict of interest with their duty to the Corporation shall be liable to the Corporation, its stockholders & other persons. The Board of Directors are not justified to purchase the stocks.

The biotech firm Amgen Inc. gives much attention and time to the planning process. Because the outcomes for a company like Amgen are often very unsure and many employees are quite sceptical about the use of such a planning, the main issue can be described as follows:

Burt's Bees is an American personal care products company that describes itself as an "Earth friendly, Natural Personal Care Company" making products for personal care, health, beauty, and personal hygiene. As of 2007, they manufactured over 197 products for facial and body skin care, lip care, hair care, baby care, men's grooming, and outdoor remedies[1] distributed in nearly 30,000 retail outlets including grocery stores and drug store chains across different countries. The original vision of Burt’s Bees founder Roxanne Quimby was to ultimately reach “everyone, everywhere”. The opportunity to grow its brand in the mass market is a lucrative

* Large Balance, $1.4B in goodwill on Merck’s Balance Sheet – the goodwill on Merck’s balance sheet is primarily attributable to past acquisitions.

AbbVie partnerships are dedicated to important outcomes: one to develop an innovative medicines and delivering a remarkable impact on people’s life.

In summary of the Pfizer case study, the organization realized executives and key employees were spending 20-40% of their time on support work rather than knowledge work. In response, the company started a “magic button” process. When an employee would like to pass off the tasks that are monotonous or lack luster they can press the “magic button”. The tasks are assigned to individuals of an outside organization for completion. The result is an increase of employee productivity.

This project is the final of three reports I will complete as part of the strategic analysis of Pfizer. This report focuses on strategic implementation and includes the following sections. First, the major concepts related to strategy implementation will be defined. Second, those concepts will be applied to the case of Pfizer in order to analyze its corporate governance, organizational structure and strategic leadership. The analysis of Pfizer will be followed by its evaluation to identify the major problem the company is facing and propose a solution. A short conclusion will close the report.